REscue of Nephrons With ALe.F02 (RENAL-F02)

Condition:   Glomerulonephritis Rapidly Progressive Interventions:   Biological: ALE.F02;   Drug: Rituximab;   Drug: GlucoCorticoid;   Drug: Cyclophosphamid;   Drug: Placebo;   Drug: Immunosuppressive Agents Sponsor:   Alentis Therapeutics AG Not yet recruiting

Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials